Harel Insurance Investments & Financial Services’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
BPC
CS
AWA
GE
PVI
PHS
Harel Insurance Investments & Financial Services's SOPH Position: Q3 2022 in Review
Harel Insurance Investments & Financial Services sold out of SOPHiA GENETICS (SOPH) in Q3 2022, closing a stake of 1,151 shares — an estimated $4K sold.
Harel Insurance Investments & Financial Services first reported a position in SOPH in Q4 2021 and held it in 2 quarters. The position peaked at $20K in Q4 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q3 2022.
- Harel Insurance Investments & Financial Services reported no remaining SOPHiA GENETICS position as of Q3 2022 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 1,151 SOPHiA GENETICS shares in Q3 2022, an estimated $4K.
- Harel Insurance Investments & Financial Services first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 2 quarters.
- Harel Insurance Investments & Financial Services's SOPHiA GENETICS position peaked at $20K in Q4 2021.
- 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2022.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2022, filed 31 Oct 2022.